Costs of asthma in a cohort of Swiss adults: Associations with exacerbation status and severity

Value in Health

Volumn 6, Issue 1, 2003, Pages 75-83

  Schwenkglenks, Matthias ^a   Lowy, Adam ^b   Anderhub, Hanspeter ^c   Szucs, Thomas D ^a  

^a Hirslanden Research   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c NONE   (Switzerland)

Author keywords

Asthma; Cost of illness; Disease severity; Economics; Resource use; Switzerland

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

ADOLESCENT; ADULT; AGE; ARTICLE; ASTHMA; CHILD; COHORT ANALYSIS; COMORBIDITY; COST OF ILLNESS; COST UTILITY ANALYSIS; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; HEALTH CARE UTILIZATION; HUMAN; LINEAR REGRESSION ANALYSIS; MEDICAL RECORD; MEDICAL SPECIALIST; MONEY; PATIENT REFERRAL; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; RETROSPECTIVE STUDY; SWITZERLAND;

EID: 0037283610     PISSN: 10983015     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4733.2003.00206.x     Document Type: Article

References (25)

1. Neri M, Spanevello A. Chronic bronchial asthma from challenge to treatment: epidemiology and social impact. Thorax 2000;55 Suppl 2:S57-8.
2. Sears MR. Descriptive epidemiology of asthma. Lancet 1997;350 Suppl 2:S1-4.
3. Sly RM. Changing prevalence of allergic rhinitis and asthma. Ann Allergy Asthma Immunol 1999;82:233-48.
4. Valdivia G. Asma bronquial y enfermedades atopicas como problema emergente de Salud Publica: nuevas hipotesis etiologicas. La experiencia de sociedades desarrolladas. Rev Med Chil 2000;128:339-46.
5. Grant EN, Wagner R, Weiss KB. Observations on emerging patterns of asthma in our society. J Allergy Clin Immunol 1999;104(2 Pt 2):S1-9.
6. Hartert TV, Peebles RS Jr. Epidemiology of asthma: the year in review. Curr Opin Pulm Med 2000;6:4-9.
7. Leuenberger P. Pollution de l'air en Suisse et maladies respiratoires chez l'adulte. Resultats preliminaires de la partie transversale de l'etude Sapaldia. Schweiz Rundsch Med Prax 1995;84:1096-100.
8. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol 2001;107:3-8.
9. Szucs TD, Anderhub HP, Rutishauser M. Determinants of health care costs and patterns of care of asthmatic patients in Switzerland. Schweiz Med Wochenschr 2000;130:305-13.
10. Szucs TD, Anderhub H, Rutishauser M. The economic burden of asthma: direct and indirect costs in Switzerland. Eur Respir J 1999;13:281-6.
11. Konkordat der Schweizerischen Krankenversicherer. Tagestaxen in Heilanstalten. Bern: Korkordat der Schweizerischen Krankenversicherer; 1999.
12. Anonymous. Arzneimittelkompendium der Schweiz. Basel: Documed; 1997.
13. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention (updated from NHLBI/WHO Workshop Report: Global Strategy for Asthma Management and Prevention, issued January 1995). NIH Publication No. 02-3659. Bethesda: National Institutes of Health. National Heart, Lung, and Blood Institute; 2002.
14. Cockcroft DW, Swystun VA. Asthma control versus asthma severity. J Allergy Clin Immunol 1996;98(6 Pt 1):1016-8.
15. Altman DG. Practical Statistics for Medical Research. 1st ed. London: Chapman & Hall/CRC; 1991.
16. Barnes PJ, Jonsson B, Klim JB. The costs of asthma. Eur Respir J 1996;9:636-42.
17. Graf von der Schulenburg JM, Greiner W, Molitor S, Kielhorn A. Kosten der Asthmatherapie nach Schweregrad. Eine empirische Untersuchung. Med Klin 1996;91:670-6.
18. Serra-Batlles J, Plaza V, Morejon E, et al. Costs of asthma according to the degree of severity. Eur Respir J 1998;12:1322-6.
19. Ungar WJ, Coyte PC, Chapman KR, MacKeigan L. The patient level cost of asthma in adults in south central Ontario. Pharmacy Medication Monitoring Program Advisory Board. Can Respir J 1998;5:463-71.
20. Malone DC, Lawson KA, Smith DH. Asthma: an analysis of high cost patients. Pharm Pract Manage Q 2000;20:12-20.
21. Hoskins G, McCowan C, Neville RG, et al. Risk factors and costs associated with an asthma attack. Thorax 2000;55:19-24.
22. Plaza V, Serra-Batlles J, Ferrer M, Morejon E. Quality of life and economic features in elderly asthmatics. Respiration 2000;67:65-70.
23. Morgan RO, Virnig BA, DeVito CA, Persily NA. The Medicare-HMO revolving door - the healthy go in and the sick go out. N Engl J Med 1997;337:169-75.
24. Age- and state-specific prevalence estimates of insured and uninsured persons in the United States 1995-96. MMWR 1998;47:529-32.
25. Rutten van Molken MP, Postma MJ, et al. Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands. Respir Med 1999;93:779-87.